---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-017306"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T00:49:55.942029+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BIO-key cures Nasdaq listing deficiencies; all periodic reports now timely filed

## Summary
- Nasdaq notified BIO-key on June 13, 2023 that it is in compliance with Listing Rule 5250(c)(1).
- Company had received deficiency notices for failure to timely file Form 10-K (year ended Dec 31, 2022) and Form 10-Q (quarter ended Mar 31, 2023).
- Form 10-K was filed on June 1, 2023; Form 10-Q was filed on June 9, 2023, curing both deficiencies.
- Previously closed Form 10-K matter and newly closed Form 10-Q matter remove all pending delisting risks.

## SEC filing metadata
- accession: 0001437749-23-017306
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774923017306/0001437749-23-017306-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774923017306/bkyi20230613_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-017306
- JSON: https://secwatch.observer/filing/0001437749-23-017306.json
- Plain text: https://secwatch.observer/filing/0001437749-23-017306.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.